According to publicly available gene array data, indoleamine-2,3-dioxygenase (IDO) is overexpressed compared to the KYNU in cancers such as ovarian, lung, and cervical, while in inflammatory diseases, KYNU is overexpressed. Here, IDO1 is linked to cancer.